Dutasteride (Avodart®), behandeling benigne prostaathyperplasie


1. IB-tekst dutasteride (Avodart®) via: www.cbg-meb.nl, Geneesmiddeleninformatiebank.
2. Roehrborn CG, et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urol 2002; 60: 434-441. 
3. Andriole GL, et al. Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol 2003; 44: 82-88. 
4. Barkin J, et al. Eur Urol 2003; 44: 461-466.  

Auteurs

  • mw drs M.L.H.A. van Oppenraay